“…The two other papers were non-comparative due to the lack of detailed information concerning the rate of T. gondii IgG antibodies to suicide, but no for IgM; therefore, they were ruled out of the quantitative analysis (Dickerson et al, 2017(Dickerson et al, , 2018. Information and characteristics of the selected studies which were included in the review are summarized in Tables 1 and 2. Out of 27 included studies, 12 articles were case-control studies (Alvarado-Esquivel et al, 2015;Alvarado-Esquivel et al, 2013;Ansari-Lari et al, 2017;Arling et al, 2009;Bak et al, 2018;Burgdorf et al, 2019;Coryell et al, 2016;Samojlowicz et al, 2013;Samojłowicz et al, 2017;Sari & Kara, 2019;Yagmur et al, 2010), 11 studies were cross-sectional (Akgül, 2019;Coccaro et al, 2016;Dickerson et al, 2017;Ene et al, 2016;Fond et al, 2015;Gale et al, 2016;Okusaga et al, 2011;Sapmaz et al, 2019;Zhang et al, 2012), and four were cohort studies (Dickerson et al, 2018;Fond et al, 2018;Pedersen et al, 2012;Sugden et al, 2016) (Table 1). As displayed in Table 2 for anti-T. gondii IgG, our meta-analysis of the 26 included data sets was performed on 64,159 individuals, including 3,804 patients with suicide disorders and 60,355 controls.…”